Cost and access in the UK For type 2 diabetes Both medications may be available through the NHS for type 2 diabetes under NICE guideline NG28, depending on your clinical profile and local formulary
For the efficacy estimand, the LSM change in HbA1c from baseline at week 52 as the primary endpoint was 2.24%, 2.43%, and 2.58% with tirzepatide 5, 10, and 15 mg, respectively, versus 1.44% with insulin glargine
At the same time, the drug development horizon is full of promising directions: oral formulations, multi-agonists, longer-acting molecules, and the emergence of biomarkers to personalize therapy
Can we get a sample before placing a bulk order
Manufacturer pricing and access agreements: Pharmaceutical companies set list prices, which are then subject to negotiation with NHS England through the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG)
Its an option that doesnt feel as high-pressure as getting a weight loss drug prescription, and its totally exceeded my expectations